SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-300039
Filing Date
2021-10-15
Accepted
2021-10-15 16:16:06
Documents
15
Period of Report
2021-10-15
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d208326d8k.htm   iXBRL 8-K 33390
2 EX-1.1 d208326dex11.htm EX-1.1 202541
3 EX-5.1 d208326dex51.htm EX-5.1 8602
7 GRAPHIC g208326sp002.jpg GRAPHIC 2831
  Complete submission text file 0001193125-21-300039.txt   435116

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cbio-20211015.xsd EX-101.SCH 2925
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbio-20211015_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbio-20211015_pre.xml EX-101.PRE 11430
8 EXTRACTED XBRL INSTANCE DOCUMENT d208326d8k_htm.xml XML 3341
Mailing Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD., SUITE 710 SOUTH SAN FRANCISCO CA 94080 650-871-0761
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

IRS No.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 211326243
SIC: 2834 Pharmaceutical Preparations